LISATA THERAPEUTICS- WILL EVALUATE EFFICACY OF CERTEPETIDE, AS PAYLOAD IN CONTEXT OF CATALENT'S SMARTAG ADC DUAL-PAYLOAD TECHNOLOGY PLATFORM

Reuters · 4d ago

Please log in to view news